Indication
Extragonadal Seminoma
1 clinical trial
3 products
4 drugs
Clinical trial
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell TumorsStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Drug
paclitaxelDrug
ifosfamideProduct
cisplatinProduct
Pegylated G-CSFDrug
FilgrastimDrug
carboplatinProduct
Etoposide